Financials

  • Market Capitalization 89.43 M
  • Employee 19
  • Founded 2011
  • CEO N/A
  • Website www.leonabio.com
  • Headquarter Washington, United States
  • FIGI BBG00C77LX40
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4031
MAIA
MAIA Biotechnology, Inc. Common Stock
1.45 USD+2.11%-3.97%+11.54%-30.29%88.16 M USD
4036
ACRV
Acrivon Therapeutics, Inc. - Common Stock
2.13 USD+7.58%+14.52%+37.42%+60.15%91.17 M USD
4050
NRXS
Neuraxis, Inc. Common Stock
7.00 USD+1.74%-2.51%+0.57%+28.91%86.69 M USD
4054
TELO
Telomir Pharmaceuticals, Inc. - Common Stock
1.24 USD0.00%0.00%-3.88%+5.08%85.28 M USD

Frequently asked questions about LeonaBio, Inc. - Common Stock

What is the LeonaBio, Inc. - Common Stock stock price today?

The current price of LeonaBio, Inc. - Common Stock (LONA) is 9.52. Over the past 24 hours, the stock has changed by -2.46%. Follow the LONA chart for real-time price dynamics.

What is the stock ticker of LeonaBio, Inc. - Common Stock?

LeonaBio, Inc. - Common Stock trades under the ticker LONA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is LeonaBio, Inc. - Common Stock stock going up?

LONA has changed by +12.13% over the last week, +11.87% over the last month, and +41.25% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was LeonaBio, Inc. - Common Stock net income for the last quarter?

LeonaBio, Inc. - Common Stock reported net income of -32.95 M for the last quarter. The previous quarter showed -82.89 M, which means net income changed by +60.25%.

How many employees does LeonaBio, Inc. - Common Stock have?

As of the latest available data, LeonaBio, Inc. - Common Stock has 19 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy LeonaBio, Inc. - Common Stock stock?

You can buy LeonaBio, Inc. - Common Stock (LONA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in LeonaBio, Inc. - Common Stock stock?

Investing in LeonaBio, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the LONA chart and related analysis on metatrader.com as part of your research.

LeonaBio, Inc. - Common Stock

Athira Pharma is a late clinical stage American biopharmaceutical company developing small-molecule therapeutics targeting neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. The company's lead candidate, ATH-1017, is in human studies for Alzheimer's disease as of 2021. The company was founded in 2011 and is headquartered in Seattle. Funding that supports the company is from both public and private investment groups including the Alzheimer's Drug Discovery Foundation, Dolby Family Ventures, the State of Washington's Life Sciences Discovery Fund, The W Fund, WRF Capital, and other private investors. Leen Kawas served as the company's first President and CEO, but resigned in October 2021, after an independent special committee found she "altered images in scientific papers she authored." In 2025, the company paid a $4 million settlement in relation to allegations that the CEO falsified research to secure a federal grant. On October 21, 2021, Mark Litton, Ph.D., M.B.A. became chief executive officer.